News | August 06, 2021
Strides to acquire US manufacturing facility of Endo for $24 mn
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
CDSCO to fast-track trials and approval for COVID19 vaccine
The data should be submitted by August 12th 2021
Innovative solutions and a deep understanding of the market makes this a unique combination
It had an estimated market size of US $ 32 million as of June 2021
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Arch Pharma Labs has filed the application
Robust demand for the product across the Middle East, Africa and Latin America
The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
Subscribe To Our Newsletter & Stay Updated
